NDC 62856-222 – Lecanemab Autoinjector
Lecanemab-irmb 200 mg/mL · Injection, Solution · Subcutaneous
Product NDC62856-222
Product details
- Brand name
- Lecanemab Autoinjector
- Generic name
- Lecanemab-irmb
- Labeler
- Eisai Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761375
- Marketed since
- July 13, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Amyloid Beta-directed Antibody
Active ingredients
- Lecanemab-irmb 200 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62856-222-02 | 2 SYRINGE, PLASTIC in 1 CARTON (62856-222-02) / 1.25 mL in 1 SYRINGE, PLASTIC (62856-222-10) | Jul 13, 2026 |
Other Lecanemab Autoinjector products
- 62856-220 Lecanemab-irmb 200 mg/mL · Injection, Solution · Eisai Inc.